88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership Group total revenue increased to RMB 3,701.4 million, representing 37.0% period-over-period growth on an AER [1] basis (41.5% growth on a CER [2] basis) Gross profit grew by 40.6% period-over-period, ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth SUZHOU, China , Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, ... 2026-08-24T Biotechnology Health Care/Hospital Medical Equipment
ASTRI and Saint Francis University Sign MoU to Advance AI-Enabled Biomaterials and Digital Health Innovation HONG KONG , Aug. 24, 2026 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU) have signed a Memorandum of Understanding (MoU) to ... 2026-08-24T Biotechnology Computer Networks Computer Software Computer/Electronics
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform" Development of Leptin receptor-based technology and hybrid LNP platform Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment for chronic-weight management and associated conditions, including obesity Total deal value of up to $2.3 billion, ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease NEW YORK , Aug. 24, 2026 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), today announced the enrollment of the ... 2026-08-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics SEONGNAM, South Korea , Aug. 24, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D SHANGHAI and HONG KONG , Aug. 24, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion TAIPEI , Aug. 24, 2026 /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that ... 2026-08-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation SHANGHAI , Aug. 21, 2026 /PRNewswire/ -- On August 21, Henlius (2696.HK) announced its interim results for the 2026 fiscal year. During the reporting period, the company showcased strong organic ... 2026-08-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved